🕵️ Apimeds Pharmaceuticals US, Inc. ($APUS)
SEC insider & ownership activity, last 12 months · CIK 1894525 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. One red-flag 8-K in the window: Delisting notice (3.01), Apr 17, 2026.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Apimeds Inc. | 34.3% | 13D | May 7, 2026 | filing ↗ | |
| Inscobee Inc. | 16.7% | 13D | May 7, 2026 | filing ↗ | |
| Ayrton Capital LLC | 10.0% | 13G | Feb 11, 2026 | filing ↗ | |
| ALTO Opportunity Master Fund, SPC - Segregated Master Portfolio B | 10.0% | 13G | Feb 11, 2026 | filing ↗ | |
| Waqas Khatri | 10.0% | 13G | Feb 11, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Jul 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 13, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 5, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 24, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 24, 2026 | filing ↗ |
| Other events (8.01) | Apr 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 24, 2026 | filing ↗ |
| Delisting notice (3.01) | Apr 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 17, 2026 | filing ↗ |
| Other events (8.01) | Apr 15, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 20, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Mar 20, 2026 | filing ↗ |
| Other events (8.01) | Mar 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 20, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 20, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Mar 20, 2026 | filing ↗ |
| Other events (8.01) | Mar 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 20, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 20, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Mar 20, 2026 | filing ↗ |
| Other events (8.01) | Mar 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 20, 2026 | filing ↗ |
| Other events (8.01) | Mar 16, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 30, 2025 | filing ↗ |
| Officer/director changes (5.02) | Dec 5, 2025 | filing ↗ |
| Acquisition or disposition (2.01) | Dec 1, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 1, 2025 | filing ↗ |
| Material agreement (1.01) | Dec 1, 2025 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Dec 1, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Dec 1, 2025 | filing ↗ |